F Bordon

Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors

Xiaoming Zhou, F Bordon, D. Sirot et al. · Antimicrobial Agents and Chemotherapy · 1994 · 120 citations · Full text

Escherichia Coli, Amino Acid Substitutions, Antibiotic Resistance +18

Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid

Emmanuelle Cambau, F Bordon, E. Collatz et al. · Antimicrobial Agents and Chemotherapy · 1993 · 85 citations · Full text

Gyra Point Mutation, Antimicrobial Susceptibility, Health Sciences +15

A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation

Isabelle Podglajen, J. Breuil, F Bordon et al. · FEMS Microbiology Letters · 1992 · 55 citations

Bacteriology, Molecular Biology, Clinical Cpmr Isolates +19

Aminoglycoside 6′- <i>N</i> -Acetyltransferase Variants of the Ib Type with Altered Substrate Profile in Clinical Isolates of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i>

I Casin, F Bordon, Philippe Bertin et al. · Antimicrobial Agents and Chemotherapy · 1998 · 51 citations · Full text

Amino Acids, Bacteriology, Pcr Mapping +21

Incidence of an aminoglycoside 6'-N-acetyltransferase, ACC (6')-1b, in amikacin-resistant clinical isolates of gram-negative bacilli, as determined by DNA-DNA hybridisation and immunoblotting

Guy Tran Van Nhieu, F Bordon, E. Collatz · Journal of Medical Microbiology · 1992 · 10 citations